Paper3501698
Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome.
Yajko DM and 2 others. Antimicrob Agents Chemother, 1987. Cited by 54 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome. Papers, record 3501698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3501698
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acquired Immunodeficiency Syndrome | Major topic |
| Anti-Bacterial Agents | Major topic |
| Mycobacterium avium | Major topic |
| Culture Media | |
| Humans | |
| Microbial Sensitivity Tests | |
| Polysorbates | |
| beta-Lactamases |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3,985,594 | Susceptibility of intra- and extracellular Mycobacterium avium-intracellulare to cephem antibiotics. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3985594 | PubMed |
| 2 | 3,972,985 | Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. | J Clin Microbiol | 1985 | https://conductscience.org/library/papers/3972985 | PubMed |
| 3 | 2,996,410 | Treatment of infections in patients with the acquired immunodeficiency syndrome. | Ann Intern Med | 1985 | https://conductscience.org/library/papers/2996410 | PubMed |
| 4 | 4,073,865 | Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4073865 | PubMed |
| 5 | 4,073,881 | Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4073881 | PubMed |
| 6 | 2,940,969 | Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/2940969 | PubMed |
| 7 | 3,771,767 | Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. | J Clin Microbiol | 1986 | https://conductscience.org/library/papers/3771767 | PubMed |
| 8 | 3,097,069 | Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. | J Clin Microbiol | 1986 | https://conductscience.org/library/papers/3097069 | PubMed |
| 9 | 3,794,396 | Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. | J Infect Dis | 1987 | https://conductscience.org/library/papers/3794396 | PubMed |
| 10 | 3,032,086 | Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3032086 | PubMed |
| 11 | 879,732 | Permeability barrier to rifampin in mycobacteria. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/879732 | PubMed |
| 12 | 7,339,819 | Basis for lack of drug susceptibility of atypical mycobacteria. | Rev Infect Dis | 1981 | https://conductscience.org/library/papers/7339819 | PubMed |
| 13 | 6,289,711 | In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin. | Am Rev Respir Dis | 1982 | https://conductscience.org/library/papers/6289711 | PubMed |
| 14 | 6,524,901 | Intra- and extracellular susceptibility of Mycobacterium avium-intracellulare complex to aminoglycoside antibiotics. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6524901 | PubMed |
| 15 | 4,004,193 | Morphological changes induced by beta-lactam antibiotics in Mycobacterium avium-intracellulare complex. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4004193 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,150,401 | Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease. | J Infect Dis | 2024 | https://conductscience.org/library/papers/38150401 | PubMed |
| 38,036,299 | Ceftriaxone Efficacy for Mycobacterium avium Complex Lung Disease in the Hollow Fiber and Translation to Sustained Sputum Culture Conversion in Patients. | J Infect Dis | 2024 | https://conductscience.org/library/papers/38036299 | PubMed |
| 32,599,854 | Structural Modifications of 3-Triazeneindoles and Their Increased Activity Against Mycobacterium tuberculosis. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32599854 | PubMed |
| 28,652,235 | Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28652235 | PubMed |
| 15,931,343 | Growth, Congo Red agar colony morphotypes and antibiotic susceptibility testing of Mycobacterium avium subspecies paratuberculosis. | Clin Med Res | 2004 | https://conductscience.org/library/papers/15931343 | PubMed |
| 10,991,858 | Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10991858 | PubMed |
| 10,582,897 | Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10582897 | PubMed |
| 8,913,479 | N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8913479 | PubMed |
| 8,851,604 | In vitro activities of rifabutin, azithromycin, ciprofloxacin, clarithromycin, clofazimine, ethambutol, and amikacin in combinations of two, three, and four drugs against Mycobacterium avium. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8851604 | PubMed |
| 8,843,278 | Susceptibility testing of Mycobacterium avium complex isolates. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8843278 | PubMed |
| 8,432,816 | Comparison of four decontamination methods for recovery of Mycobacterium avium complex from stools. | J Clin Microbiol | 1993 | https://conductscience.org/library/papers/8432816 | PubMed |
| 8,408,551 | Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. | J Clin Microbiol | 1993 | https://conductscience.org/library/papers/8408551 | PubMed |
| 8,358,707 | The Mycobacterium avium complex. | Clin Microbiol Rev | 1993 | https://conductscience.org/library/papers/8358707 | PubMed |
| 8,239,587 | Anti-Mycobacterium avium activity of quinolones: in vitro activities. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8239587 | PubMed |
| 7,986,010 | In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7986010 | PubMed |
| 7,872,747 | A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7872747 | PubMed |
| 7,698,124 | Antimycobacterial susceptibility testing: present practices and future trends. | Eur J Clin Microbiol Infect Dis | 1994 | https://conductscience.org/library/papers/7698124 | PubMed |
| 7,535,036 | Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7535036 | PubMed |
| 3,196,000 | Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3196000 | PubMed |
| 2,808,669 | Differences in antimicrobial susceptibility of pigmented and unpigmented colonial variants of Mycobacterium avium. | J Clin Microbiol | 1989 | https://conductscience.org/library/papers/2808669 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3501698
GET https://conductscience.org/api/papers/v1/3501698/cited_by?page=2